This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)
C3_PALATE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
213 |
4. Check minimum number of eventsNone |
213 |
5. Include endpointsNone |
213 |
6. Filter based on genotype QC (FinnGen only) |
213 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 213 | 114 | 99 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 60.76 | 59.42 | 62.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 77
- Matched controls
- 769
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
+∞
46.7
40
*
130
Kela drug reimbursment
Malignant tumour
+∞
37.6
33
*
EHB00
NOMESCO Finland
Excision of lesion of palate
+∞
33.9
30
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
215.7
28.8
28
*
WF002
NOMESCO Finland
Radical radiotherapy
363.2
26.4
25
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
128.2
25.5
26
*
8070/3-C05.1
ICD-O-3
Squamous cell carcinoma, NOS, of soft palate, NOS
+∞
25.4
23
*
EHA10
NOMESCO Finland
Biopsy of palate
342.2
25.2
24
*
C05.0
ICD-10 Finland
Malignant neoplasm: Hard palate
+∞
24.2
22
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
107.3
22.1
23
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
24.2
17.0
24
14
EP1AE
NOMESCO Finland
Neck ultrasound examination
26.6
16.8
23
12
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
16.2
15
*
A03FA01
ATC
metoclopramide; systemic, rectal
13.0
15.6
29
34
R4190
NOMESCO Finland
Nutritional therapy
29.4
15.2
20
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
183.4
15.0
15
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
7.7
15.0
44
113
GBB00
NOMESCO Finland
Tracheostomy
53.5
14.8
17
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
26.4
14.7
20
10
N02AA05
ATC
oxycodone; systemic
10.3
14.6
31
47
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
14.0
13
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
14.0
13
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
12.9
12
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
77.0
12.0
13
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
21.3
11.8
17
10
ZX090
NOMESCO Finland
Other technic of radiotherapy
140.1
11.8
12
*
EBA10
NOMESCO Finland
Surgical removal of tooth
12.7
11.7
21
22
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
8.2
11.6
28
50
WX408
NOMESCO Finland
General anesthesy, balanced
6.2
11.5
37
99
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
126.5
10.7
11
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.7
10
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
10.7
10
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
10.7
10
*
8070/3-C05.9
ICD-O-3
Squamous cell carcinoma, NOS, of palate, NOS
+∞
10.7
10
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
5.1
10.4
51
214
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
30.8
10.2
13
5
SAA03
NOMESCO Finland
Extended examination of mouth
5.0
10.1
46
176
WX110
NOMESCO Finland
Local anesthesy
6.5
9.7
67
391
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
113.4
9.6
10
*
SBB10
NOMESCO Finland
Teeth copy
10.1
9.6
19
24
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.6
9
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
42.1
9.3
11
*
Z51.5
ICD-10 Finland
Palliative care
28.0
9.2
12
5
UDQ12
NOMESCO Finland
Flexible laryngoscopy
11.1
9.1
17
19
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
31.6
8.7
11
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
31.6
8.7
11
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
100.6
8.6
9
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
100.6
8.6
9
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
8.3
8.6
19
29
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.5
8
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
8.5
8
*
C05.9
ICD-10 Finland
Malignant neoplasm: Palate, unspecified
+∞
8.5
8
*
C05.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of palate
+∞
8.5
8
*
WX402
NOMESCO Finland
General anaesthesia
5.7
8.4
26
63
SPF20
NOMESCO Finland
Temporary soling for filling
37.7
8.3
10
*
H02AB02
ATC
dexamethasone; systemic
25.2
8.3
11
5
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
50.3
7.9
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
10.0
7.8
15
18
WX404
NOMESCO Finland
Intravenous generell anesthesy
5.0
7.7
27
75
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.9
7.6
27
76
K13.78
ICD-10 Finland
Other change in the oral mucosa
88.2
7.6
8
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
88.2
7.6
8
*
A04AA01
ATC
ondansetron; systemic, rectal
18.0
7.5
11
7
8070/3-C05.0
ICD-O-3
Squamous cell carcinoma, NOS, of hard palate
+∞
7.4
7
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
7.4
7
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
+∞
7.4
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.4
7
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
33.5
7.3
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
7.3
46
217
K05.31
ICD-10 Finland
Periodontitis pronounced
6.3
7.1
19
38
A07AA02
ATC
nystatin; oral
7.8
7.1
16
25
JN4BD
NOMESCO Finland
Extensive body CT
10.2
6.9
13
15
A06AD11
ATC
lactulose; oral
5.2
6.8
22
55
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
11.6
6.8
12
12
SAA04
NOMESCO Finland
Special inverstigation of mouth
8.7
6.8
14
19
ZXA05
NOMESCO Finland
Left side
3.9
6.6
33
125
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
75.9
6.5
7
*
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
75.9
6.5
7
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
20.1
6.4
9
5
J01DB01
ATC
cefalexin; oral
5.6
6.4
70
493
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
29.3
6.4
8
*
UJC01
NOMESCO Finland
Scopy of lower throat
29.3
6.4
8
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
6.3
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
EBA00
NOMESCO Finland
Extraction of tooth
3.5
6.2
37
160
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
61
46
18.18
67.67
1.5
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
67
119
7.76
38.96
2.6
1.9
g/l
0.2
0.2
0.14
67
108
(40768804) Tissue Pathology biopsy report
127
512
4.67
27.60
3.5
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
57
171
4.19
17.38
2.0
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
48
128
4.55
17.05
1.6
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
89
377
3.34
16.00
4.2
3.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
56
194
3.56
13.62
5.9
4.5
mmol/l
1.0
1.0
0.33
56
175
(40758558) Short blood count panel - Blood
82
363
3.05
13.26
7.8
4.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
91
433
2.92
12.84
3.7
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
25
7.77
12.47
1.4
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
99
520
2.69
11.23
4.5
2.0
mmol/l
2.4
2.4
0.07
93
430
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
130
796
2.62
10.57
8.9
5.0
mmol/l
1.2
1.2
1.77
111
678
(3003396) Base excess in Arterial blood by calculation
47
171
3.24
10.39
9.3
6.4
mmol/l
1.2
1.5
0.21
40
132
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
115
672
2.55
10.20
5.6
3.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
137
870
2.61
10.17
11.8
6.4
e9/l
4.2
4.2
0.00
121
754
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
121
728
2.53
10.03
7.9
4.5
mmol/l
1.2
1.2
0.36
115
642
(3020779) Urea [Moles/volume] in Serum or Plasma
37
121
3.49
9.65
4.3
6.2
mmol/l
7.3
10.2
2.21
37
115
(3018418) pH of Serum or Plasma
88
473
2.47
9.10
4.3
2.9
ph
7.4
7.4
0.55
20
78
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
69
333
2.59
8.95
3.4
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
108
658
2.30
8.18
6.8
8.9
inr
1.1
1.3
3.04
26
193
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
92
527
2.31
8.03
3.1
2.6
u/l
36.6
30.2
0.84
87
496
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
28
88
3.51
7.71
10.3
7.2
%
0.8
0.7
0.32
28
88
(3042936) Bacteria identified in Isolate by Culture
49
222
2.57
7.08
1.9
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
36
148
2.72
6.28
10.9
6.7
g/l
117.4
122.8
0.73
36
143
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
36
151
2.67
6.03
3.3
2.0
u/l
31.8
33.5
0.16
31
121
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
163
1265
2.23
5.83
10.3
5.1
u/l
82.6
75.5
1.34
155
1156
(3026389) Candida sp identified in Specimen by Organism specific culture
12
24
5.24
5.81
2.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
27
99
2.98
5.78
8.1
4.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
25
89
3.05
5.63
10.8
7.3
%
2.1
1.4
1.54
25
89
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
46
230
2.28
5.27
1.7
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
260
2.21
5.21
2.0
2.5
e6/l
1.2
0.9
0.27
26
140
(3030467) Casts [#/volume] in Urine by Automated count
71
428
1.99
4.99
2.6
2.7
e6/l
1.7
0.4
0.83
50
310
(3022096) Basophils/100 leukocytes in Blood
102
708
1.85
4.59
7.0
5.2
%
0.6
0.7
0.77
94
648
(3002030) Lymphocytes/100 leukocytes in Blood
106
745
1.84
4.58
6.9
5.4
%
24.2
27.7
2.21
97
684
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
240
2.11
4.36
2.1
2.7
e6/l
2.8
2.6
0.03
21
120
(3018010) Neutrophils/100 leukocytes in Blood
105
744
1.81
4.35
6.5
5.2
%
60.1
57.2
1.48
98
691
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
85
2.77
4.30
9.0
5.2
mmol/l
25.6
25.1
0.22
22
85
(42870588) Differential panel, method unspecified - Blood
79
515
1.85
4.29
6.4
5.2
—
—
—
0
0
(3020891) Body temperature
18
62
3.08
4.29
6.1
3.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
163
2.29
4.27
1.4
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
103
733
1.78
4.15
7.1
5.2
%
2.7
3.0
0.69
96
673
(36304419) Bacteria [Presence] in Urine
67
418
1.88
4.15
2.6
2.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
110
799
1.78
4.13
6.5
5.2
e9/l
1.6
1.8
1.12
95
697
(3019069) Monocytes/100 leukocytes in Blood
103
735
1.78
4.10
7.2
5.5
%
9.2
8.5
1.32
96
678
(3013115) Eosinophils [#/volume] in Blood
112
820
1.77
4.07
6.5
5.1
e9/l
0.2
0.2
0.24
95
715
(3000991) Gas panel - Venous blood
26
114
2.46
3.97
9.7
6.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
108
788
1.75
3.93
6.5
5.1
e9/l
0.6
0.6
1.24
88
670
(3018095) Leukocytes [#/volume] in Urine
82
554
1.78
3.89
3.0
3.3
e6/l
24.2
113.8
1.07
52
386
(3044889) 12 lead EKG panel
153
1238
1.84
3.86
4.4
3.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
40
214
2.07
3.83
2.9
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
108
794
1.73
3.78
6.5
5.1
e9/l
0.0
0.0
1.47
90
681
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
85
2.63
3.76
1.2
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
165
2.18
3.75
1.4
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
70
464
1.76
3.48
2.7
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
99
724
1.69
3.44
13.1
7.9
e9/l
0.0
0.0
0.50
74
595
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
123
2.27
3.37
2.9
2.0
ml/min/173m2
64.4
64.0
0.02
12
47
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
49
297
1.84
3.26
4.7
2.1
mmol/l
2.5
2.4
1.46
43
252
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
33
3.46
3.24
1.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
39
222
1.93
3.13
2.3
2.2
umol/l
10.3
13.8
2.63
39
202
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
100
2.34
3.12
1.6
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
69
468
1.70
3.12
2.7
2.8
e6/l
26.2
173.3
0.53
47
354
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
78
548
1.67
3.08
2.6
2.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
8
7.67
3.07
3.0
1.5
ug/l
29.7
18.7
—
6
8
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
93
693
1.61
2.87
2.1
2.3
nmol/l
76.9
80.1
0.46
87
608
(3000492) Spirometry study
28
146
2.06
2.86
1.6
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
31
168
1.99
2.86
1.6
1.9
%
1.6
1.6
0.01
25
149
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
36
3.17
2.85
1.5
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
6
8.49
2.76
1.6
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
6
8.49
2.76
1.2
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
87
2.30
2.66
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
33
188
1.89
2.64
2.3
2.3
%
20.1
23.7
0.76
28
163
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
34
3.04
2.44
1.2
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
47
308
1.67
2.36
2.0
1.7
nmol/l
1197.9
1219.7
0.06
38
226
(3037467) Urinalysis macro (dipstick) panel - Urine
134
1118
1.54
2.34
3.9
4.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
73
2.29
2.27
10.4
7.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
192
0.39
2.18
1.5
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
14
4.38
2.16
3.3
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
54
376
1.58
2.13
2.0
2.0
mg/l
2.7
2.9
0.43
47
309
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
10
5.09
2.08
2.0
2.7
nmol/l
2.4
3.6
—
5
10
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
345
1.59
2.04
3.8
3.8
ng/l
207.3
182.2
0.05
42
276
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
22
120
1.93
2.01
4.0
2.7
mmol/l
1.3
1.2
0.89
22
98
(21494434) Karyotype in Bone marrow
6
16
3.83
1.95
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
22
3.25
1.89
1.1
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
82
639
1.46
1.89
2.4
2.6
ug/l
216.4
119.6
2.43
77
584
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
28
2.93
1.88
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
294
0.51
1.88
1.3
1.3
u/ml
1.9
15.2
—
6
102
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
185
1694
1.70
1.87
23.2
11.5
mg/l
32.0
21.3
4.00
165
1300
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
90
716
1.45
1.85
2.2
1.9
pmol/l
91.9
95.7
0.30
53
341
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
12
4.24
1.83
6.0
2.0
u/ml
3452.2
311.7
—
5
12
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
9
35
2.64
1.82
1.7
2.3
g/l
3.6
3.8
—
9
35
(3013512) EKG study
38
546
0.63
1.81
3.8
3.8
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
5
13
3.91
1.72
2.6
2.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
13
3.91
1.72
1.4
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
13
3.91
1.72
1.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
19
3.22
1.67
1.0
2.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
194
1812
1.79
1.65
26.1
13.9
mmol/l
138.9
139.9
4.13
189
1746
(21494890) Protein electrophoresis panel - 24 hour Urine
5
14
3.63
1.62
1.2
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
47
632
0.67
1.62
2.8
3.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
112
944
1.39
1.60
2.9
2.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
242
0.51
1.59
3.4
4.7
%
39.3
32.0
—
8
161
(3023103) Potassium [Moles/volume] in Serum or Plasma
194
1815
1.77
1.59
25.8
13.9
mmol/l
3.9
4.0
1.76
189
1750
(4010399)
24
146
1.73
1.59
1.3
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
393
1.46
1.54
1.5
1.5
nmol/l
22.0
22.5
0.06
47
331
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
21
2.91
1.51
2.8
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
23
2.65
1.37
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
23
2.65
1.37
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
48
624
0.70
1.34
4.1
4.1
mg/mmol
9.3
8.0
0.12
29
386
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
76
1.90
1.33
1.8
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
8
34
2.40
1.30
2.5
2.2
kpa
5.4
5.0
—
8
34
(3027315) Oxygen [Partial pressure] in Blood
8
34
2.40
1.30
2.5
2.2
kpa
8.5
8.1
—
8
34
(3009508) Creatinine [Moles/volume] in Urine
47
608
0.71
1.27
3.3
3.2
mmol/l
7.8
7.3
0.31
38
501
(40761511) CBC panel - Blood by Automated count
190
1788
1.58
1.26
19.3
11.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
133
1.64
1.23
1.9
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
19
2.67
1.22
1.2
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
19
2.67
1.22
1.4
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
43
324
1.41
1.15
2.3
2.2
e6/l
5.1
4.8
0.08
38
281
(3003694) ABO and Rh group [Type] in Blood
48
369
1.39
1.15
1.5
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
46
588
0.72
1.14
3.3
3.3
mg/l
45.9
273.1
0.82
30
367
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
30
2.38
1.13
1.3
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
92
784
1.31
1.11
4.1
4.8
estimate
0.0
0.0
0.00
16
137
(3013707) Erythrocyte sedimentation rate by Westergren method
143
1294
1.32
1.10
3.5
4.1
mm/h
16.8
11.5
2.92
133
1177
(3011397) Hemoglobin [Presence] in Urine by Test strip
47
363
1.38
1.09
3.3
3.4
—
—
—
0
0
(3012544) pH of Venous blood
23
154
1.55
1.09
2.7
3.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
91
777
1.30
1.07
3.1
3.6
estimate
0.0
0.0
0.00
15
139
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
22
2.30
1.04
1.6
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
47
1.95
1.03
2.0
3.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
222
0.60
1.01
1.1
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
23
2.20
0.98
1.2
3.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
36
1.98
0.98
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
37
1.92
0.95
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
28
2.18
0.92
2.8
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
29
2.10
0.90
3.0
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
123
1108
1.26
0.89
2.9
2.9
u/l
57.2
44.8
0.88
112
1025
(3009542) Hematocrit [Volume Fraction] of Blood
163
1520
1.31
0.89
24.2
12.7
%
38.0
40.2
2.83
119
1030
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
31
232
1.39
0.87
1.6
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
44
1.85
0.87
2.8
2.9
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
191
1826
1.45
0.86
26.9
13.9
umol/l
73.5
77.8
1.97
191
1826
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
6
113
0.52
0.86
1.0
1.3
—
38.1
—
0
9
(3009261) Glucose [Presence] in Urine by Test strip
91
795
1.25
0.85
3.1
3.6
estimate
0.0
0.0
0.00
15
132
(3022145) Colonoscopy Study observation
24
172
1.45
0.85
1.5
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
38
296
1.35
0.85
2.5
2.5
mosm/kgh2o
543.7
554.8
0.10
30
246
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
32
1.90
0.82
4.5
1.9
—
—
—
0
0
(3015736) pH of Urine
72
616
1.26
0.80
3.0
3.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
20
140
1.47
0.80
3.3
2.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
33
1.84
0.79
1.2
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
164
1727
0.78
0.75
4.6
4.8
mmol/l
5.9
6.0
0.49
150
1555
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
55
1.66
0.74
2.8
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
305
0.72
0.72
1.2
1.3
iu/ml
10.3
39.9
—
9
95
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
40
1.77
0.72
4.1
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
166
1743
0.78
0.72
4.1
4.8
mmol/l
1.5
1.5
0.11
148
1592
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
94
1.52
0.68
2.5
2.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
8
126
0.62
0.66
2.8
2.4
nmol/l
11.2
15.6
—
8
116
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
51
1.59
0.61
1.5
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
51
1.59
0.61
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
51
1.59
0.61
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
51
1.59
0.61
1.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
21
0.00
0.60
0.0
2.6
—
9.2
—
0
15
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
38
1.60
0.55
2.2
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
139
1305
1.19
0.54
3.7
3.9
pmol/l
14.5
14.9
1.16
129
1168
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
172
1786
0.81
0.54
4.6
5.5
mmol/l
2.7
2.7
0.06
153
1637
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
50
577
0.83
0.54
4.8
3.7
ug/l
2.3
1.9
0.24
43
512
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
171
1637
1.23
0.53
20.8
10.8
ml/min/173m2
82.5
78.2
2.04
149
1309
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
161
1680
0.83
0.52
3.7
4.3
mmol/l
1.4
1.3
0.90
143
1525
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
7
47
1.51
0.48
1.1
1.3
—
1.5
—
0
5
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
47
1.51
0.48
1.0
1.2
—
3.0
—
0
9
(3019225) pH of Specimen
12
164
0.72
0.47
9.3
3.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
169
1751
0.83
0.46
4.1
4.9
mmol/l
4.7
4.7
0.29
155
1608
(3019832) Treponema pallidum Ab [Presence] in Serum
11
78
1.43
0.44
2.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
149
1.30
0.43
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
32
1.58
0.42
2.4
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
214
1.24
0.42
6.3
5.9
—
—
—
0
0
(4027681)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
1.1
—
0
9
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
161
1670
0.85
0.41
5.1
6.3
mmol/mol
39.4
40.3
0.71
150
1545
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(4268621)
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(4024509)
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
35
1.44
0.39
1.6
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
161
1.27
0.38
4.6
3.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
41
1.48
0.36
1.7
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
118
1.29
0.34
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
188
1836
1.20
0.33
13.4
8.9
u/l
26.7
25.6
0.18
180
1750
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
164
1590
1.14
0.30
4.8
4.7
mu/l
2.1
1.9
0.54
145
1433
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
64
1.26
0.28
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
40
359
1.14
0.27
1.6
1.6
mg/l
0.9
1.0
0.26
33
274
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
42
464
0.88
0.27
4.0
3.6
%
18.4
24.5
2.04
18
207
(3029937) Albumin [Presence] in Urine by Test strip
47
427
1.13
0.27
3.8
3.9
estimate
0.0
0.0
0.00
16
131
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
86
1.29
0.26
2.0
2.0
%
1.4
1.1
0.43
11
86
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
67
624
1.11
0.25
3.3
3.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
46
503
0.89
0.25
1.9
1.7
mmol/l
1.7
1.3
1.26
41
413
(46235355) HIV 1 and 2 tests - Meaningful Use set
21
180
1.18
0.25
2.5
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
81
0.73
0.24
1.3
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
31
347
0.88
0.24
1.2
1.3
u/ml
6.1
1.7
—
7
93
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
16
135
1.20
0.22
3.6
3.5
ng/l
65.2
80.0
0.72
16
119
(3035320) C reactive protein [Mass/volume] in Body fluid
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
10
0.00
0.21
0.0
2.1
—
2122.0
—
0
10
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.2
—
8.3
—
0
10
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
12
0.00
0.21
0.0
2.5
—
13.1
—
0
12
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
52
1.16
0.19
1.3
1.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
60
1.17
0.18
1.0
1.2
—
1.7
—
0
6
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
66
0.75
0.17
3.0
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
15
172
0.86
0.16
1.9
2.3
ug/l
8.6
7.9
0.06
15
151
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
66
694
0.93
0.16
4.4
3.5
ng/l
19.1
36.4
2.32
45
487
(3009445) Proteinase 3 Ab [Units/volume] in Serum
8
72
1.12
0.16
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
80
0.74
0.15
2.2
3.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
79
1.15
0.15
1.0
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
121
1.17
0.15
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
81
1.12
0.15
1.1
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
26
238
1.11
0.13
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
39
365
1.08
0.13
1.6
1.8
pmol/l
488.7
452.2
0.18
30
288
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
107
0.83
0.13
1.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
109
0.82
0.13
6.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
147
0.88
0.12
1.8
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
86
1.17
0.11
2.8
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
66
1.06
0.08
1.6
2.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
7
85
0.82
0.07
2.0
2.9
pmol/l
4.2
4.4
—
7
73
(40760892) CBC W Ordered Manual Differential panel - Blood
33
345
0.95
0.06
4.8
4.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
32
332
0.96
0.04
2.0
2.6
ug/l
0.8
0.7
0.29
19
209
(3002179) Metamyelocytes/100 leukocytes in Blood
11
101
1.09
0.04
11.1
5.1
%
0.3
0.4
—
6
17
(3007164) IgA [Mass/volume] in Serum or Plasma
31
299
1.04
0.04
1.4
1.3
g/l
2.6
2.6
0.05
16
176
(3026493) Urate [Moles/volume] in Serum or Plasma
44
434
1.02
0.00
3.1
2.3
umol/l
9435.8
6370.0
0.13
39
369
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
106
1.04
0.00
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
97
1.03
0.00
3.1
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
43
433
0.99
0.00
2.7
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
135
0.96
0.00
3.9
3.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.4
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
13.1
—
0
7
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
214.2
—
0
6
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44813793)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
9
0.00
0.00
0.0
12.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
96
0.93
0.00
1.3
2.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
1.0
—
0
8
(3049717) Cytology report of Urine Cyto stain
5
49
1.02
0.00
1.2
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
72
0.97
0.00
2.7
3.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
7.6
—
1055.4
—
0
9
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
49
1.02
0.00
1.4
1.2
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(1002224) Polysomnography panel
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
9.0
—
1459.0
—
0
9
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
9
96
0.93
0.00
2.7
3.6
kpa
5.3
5.1
—
9
91
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
78.6
—
0
5
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
7.2
—
0.6
—
0
9
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.0
—
0
5
(4211845)
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PALATE_EXALLC – Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).